The U.S. Food and Drug Administration (FDA) recently announced that it would be requiring a new, high-level warning on labels for the type 2 diabetes drug canagliflozin. Sold under the brand names and formulations Invokana, Invokamet, and Invokamet XR, this popular medication for lowering blood sugar levels has been found in new clinical trial data […]
On April 25, the U.S. Food and Drug Administration (FDA) sent out warning letters to 14 different American companies, which collectively are selling over 65 products for cancer treatment, prevention, diagnosis, or a cure. None of these products has been approved by the FDA, which means that the claims made by the companies selling them […]